Show simple item record

dc.contributor.authorLunardi, Mattia
dc.contributor.authorWu, Sijing
dc.contributor.authorSerruys, Patrick W
dc.contributor.authorOnuma, Yoshinobu
dc.contributor.authorSoliman, Osama
dc.contributor.authorWijns, William
dc.contributor.authorMullens, Wilfried
dc.contributor.authorSharif, Faisal
dc.date.accessioned2024-09-10T13:04:26Z
dc.date.available2024-09-10T13:04:26Z
dc.date.issued2022-02-07
dc.identifier.pmid35132779
dc.identifier.doi10.1002/ehf2.13819
dc.identifier.urihttp://hdl.handle.net/10147/642818
dc.descriptionMore than half of heart failure (HF) patients have concomitant pulmonary hypertension, impacting symptoms and prognosis. The role of exercise in this category of patients is still unclear, probably because of the lack of a clear relationship between exercise and acute and chronic pulmonary artery pressure variations and related changes in symptoms. The limited evidence on this topic is contradictory and hardly comparable due to use of different exercise programmes and pulmonary artery pressure assessment techniques. This is further compounded by different functional and structural classes of HF making definite assessments and interpretations of exercise effect on outcomes difficult. Exercise training programmes were proven beneficial in HF patients; however, the lack of data about their pulmonary haemodynamic effects prevents clear indications on the best exercise types for patients presenting secondary pulmonary hypertension and different HF categories. Indeed, some data suggest that not all HF patients have similar responses to training, leading to either beneficial or detrimental effects, depending on the HF type. Future studies, involving modern technologies such as continuous pulmonary artery pressure monitoring implantable devices, may clarify the current gaps in this field, aiming at patient-tailored exercise training rehabilitation programmes, in order to improve clinical outcomes, quality of life, and hopefully prognosis.en_US
dc.language.isoenen_US
dc.rights© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectExerciseen_US
dc.subjectHeart failure programmesen_US
dc.subjectImplantable monitorsen_US
dc.subjectpulmonary hypertensionen_US
dc.titleAcute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms.en_US
dc.typeArticleen_US
dc.identifier.eissn2055-5822
dc.identifier.journalESC heart failureen_US
dc.source.journaltitleESC heart failure
dc.source.volume9
dc.source.issue2
dc.source.beginpage791
dc.source.endpage799
refterms.dateFOA2024-09-10T13:04:28Z
dc.source.countryEngland


Files in this item

Thumbnail
Name:
EHF2-9-791.pdf
Size:
2.997Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Except where otherwise noted, this item's license is described as © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.